Literature DB >> 17233843

Primary large B-cell lymphoma of the bone marrow.

Masakatsu Hishizawa1, Kohei Okamoto, Kazuhisa Chonabayashi, Hitomi Kaneko, Mitsumasa Watanabe, Mitsuru Tsudo.   

Abstract

Mesh:

Substances:

Year:  2007        PMID: 17233843     DOI: 10.1111/j.1365-2141.2006.06336.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  5 in total

1.  Primary diffuse large B-cell lymphoma of the bone marrow in a frail and elderly patient successfully treated with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone.

Authors:  Pasquale Niscola; Massimiliano Palombi; Stefano Fratoni; Alessio Perrotti; Paolo de Fabritiis
Journal:  Blood Res       Date:  2013-12-24

2.  Fever and arthralgia as the initial symptoms of primary bone marrow diffuse large B-cell lymphoma: A case report.

Authors:  Saisai Ren; Yanling Tao; L U Jia; Panpan Cheng; Jilei Zhang; Hao Zhang
Journal:  Oncol Lett       Date:  2016-04-04       Impact factor: 2.967

3.  Bone marrow large B cell lymphoma bearing cyclin D3 expression: clinical, morphologic, immunophenotypic, and genotypic analyses of seven patients.

Authors:  Jyuri Watanuki; Kinta Hatakeyama; Takashi Sonoki; Hiro Tatetsu; Katsuhiko Yoshida; Soichiro Fujii; Minoru Mizutani; Toru Abo; Miwa Kurimoto; Hiroshi Matsuoka; Fumihiko Matsuno; Hideki Nakakuma
Journal:  Int J Hematol       Date:  2009-07-29       Impact factor: 2.490

4.  Primary bone marrow lymphoma: A hematological emergency in adults with fever of unknown origin.

Authors:  Hao-Yuan Wang; Ching-Fen Yang; Tzeon-Jye Chiou; Jyh-Pyng Gau; Po-Min Chen; Chang-Youh Tsai; Hui-Chi Hsu; Fu-der Wang; Jin-Hwang Liu; Liang-Tsai Hsiao
Journal:  Cancer Med       Date:  2018-07-09       Impact factor: 4.452

5.  Long-term remission of primary bone marrow diffuse large B-cell lymphoma treated with high-dose chemotherapy rescued by in vivo rituximab-purged autologous stem cells.

Authors:  Hiroshi Kazama; Masanao Teramura; Kentaro Yoshinaga; Akihiro Masuda; Toshiko Motoji
Journal:  Case Rep Med       Date:  2012-10-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.